Below are the most recent publications written about "Cedrus" by people in Profiles.
-
Fujimura T, Fujinami K, Ishikawa R, Tateno M, Tahara Y, Okumura Y, Ohta H, Miyazaki H, Taniguchi M. Recombinant Fusion Allergens, Cry j 1 and Cry j 2 from Japanese Cedar Pollen, Conjugated with Polyethylene Glycol Potentiate the Attenuation of Cry j 1-Specific IgE Production in Cry j 1-Sensitized Mice and Japanese Cedar Pollen Allergen-Sensitized Monkeys. Int Arch Allergy Immunol. 2015; 168(1):32-43.
-
Lee B, Kim KH, Jung HJ, Kwon HJ. Matairesinol inhibits angiogenesis via suppression of mitochondrial reactive oxygen species. Biochem Biophys Res Commun. 2012 Apr 27; 421(1):76-80.
-
Yamanaka K, Yuta A, Kakeda M, Kitagawa H, Ogihara H, Gabazza EC, Okubo K, Kurokawa I, Takeuchi K, Mizutani H. SLIT improves cedar pollinosis by restoring IL-10 production from Tr1 and Monocytes~IL-10 productivity is critical for becoming allergic~. Allergol Int. 2011 Mar; 60(1):45-51.
-
Enomoto T, Ide T, Ogino S. Construction of an environmental exposure unit and investigation of the effects of cetirizine hydrochloride on symptoms of cedar pollinosis in Japan. J Investig Allergol Clin Immunol. 2007; 17(3):173-81.
-
Toda M, Kasai M, Hosokawa H, Nakano N, Taniguchi Y, Inouye S, Kaminogawa S, Takemori T, Sakaguchi M. DNA vaccine using invariant chain gene for delivery of CD4+ T cell epitope peptide derived from Japanese cedar pollen allergen inhibits allergen-specific IgE response. Eur J Immunol. 2002 Jun; 32(6):1631-9.
-
Masuda K, Sakaguchi M, Saito S, Deboer DJ, Yamashita K, Hasegawa A, Ohno K, Tsujimoto H. Seasonal atopic dermatitis in dogs sensitive to a major allergen of Japanese cedar (Cryptomeria japonica) pollen. Vet Dermatol. 2002 Feb; 13(1):53-59.
-
Sakaguchi M, Yamada T, Hirahara K, Shiraishi A, Saito S, Miyazawa H, Taniguchi Y, Inouye S, Nigi H. Seasonal changes of humoral and cellular immune responses to Japanese cedar (Cryptomeria japonica) pollen allergens in Japanese monkeys (Macaca fuscata) with pollinosis. J Med Primatol. 2001 Apr; 30(2):112-20.